较高外源性促性腺激素剂量增加新鲜胚胎移植后单胎小于胎龄儿风险
这项回顾性队列研究纳入2020例新鲜胚胎移植后活产单胎,按促性腺激素总剂量分三组,发现总剂量超过2500 IU组经多因素回归校正后小于胎龄儿率显著高于≤1800 IU组(aOR 2.25,95%CI 1.24至4.08),作者认为总剂量宜不超过2500 IU。
要点
- 促性腺激素总剂量>2500 IU组校正后小于胎龄儿率显著高于≤1800 IU组(aOR 2.25,95%CI 1.24至4.08)。
- 分层分析中GnRH激动剂长方案(aOR 2.09,95%CI 1.02至5.17)与拮抗剂方案(aOR 2.75,95%CI 1.05至7.22)均见小于胎龄儿率升高。
- 作者认为卵巢刺激总促性腺激素剂量最好不超过2500 IU。
核心结论
- 对于无多囊卵巢综合征的患者,卵巢刺激时总促性腺激素剂量超过2500 IU可能通过增加新鲜胚胎移植后单胎小于胎龄儿率而对新生儿结局产生不良影响。
- 作者认为卵巢刺激期间给予的总促性腺激素剂量最好不超过2500 IU。
研究设计与样本
- 回顾性队列研究,纳入2020例新鲜胚胎移植后活产单胎,评估新生儿结局。
- 所有患者于2016年8月1日至2020年4月30日期间接受自体IVF周期并在新鲜胚胎移植后活产单胎。
- 排除多囊卵巢综合征患者。
- 按促性腺激素总剂量分为3组:1组≤1800 IU;2组1801-2500 IU;3组>2500 IU。
主要发现
- 经多因素回归模型校正混杂因素后,3组小于胎龄儿校正率显著高于1组(aOR 2.25,95%CI 1.24至4.08)。
- 促性腺激素总剂量超过2500 IU相较于低于1800 IU,小于胎龄儿风险增加2.25倍。
- 分层分析显示,GnRH激动剂长方案中小于胎龄儿率升高(aOR 2.09,95%CI 1.02至5.17)。
- 分层分析显示,拮抗剂方案中小于胎龄儿率升高(aOR 2.75,95%CI 1.05至7.22)。
临床怎么用
- 作者认为卵巢刺激期间给予的总促性腺激素剂量最好不超过2500 IU。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: A negative relationship has been reported between exogenous gonadotrophin dosage and the live birth rate in IVF. It is unclear whether total gonadotrophin dosage is associated with neonatal outcomes. The effect of exogenous gonadotrophin dosage on neonatal outcomes of singletons after fresh embryo transfer (FET) was investigated. DESIGN: A retrospective cohort study of 2020 live singletons evaluating neonatal outcomes. All patients underwent autologous IVF cycles between 1 August 2016 and 30 April 2020 and delivered a live singleton birth after FET. Patients with polycystic ovary syndrome were excluded. Patients were divided according to total gonadotrophin dose: group 1: ≤1800 IU; group 2: 1801-2500 IU; and group 3: >2500 IU. RESULTS: After adjusting for confounding factors by multiple regression models, the adjusted rate of small for gestational age (SGA) was significantly higher in group 3 (adjusted [a]OR 2.25, 95% CI 1.24 to 4.08). The risk of SGA increased 2.25 times when total gonadotrophin dose exceeded 2500 IU versus gonadotrophin doses below 1800 IU. The hierarchical analysis showed that an increased rate of SGA infants occurred in the GnRH agonist long protocol (aOR 2.09, 95% CI 1.02 to 5.17) and in the antagonist protocol (aOR 2.75, 95% CI 1.05 to 7.22). CONCLUSIONS: For patients without polycystic ovary syndrome, an excessive total gonadotrophin dose during ovarian stimulation, i.e. more than 2500 IU, may negatively affect neonatal outcomes by increasing the SGA rate of singletons after FET. Therefore, total gonadotrophin dose administered during ovarian stimulation should preferably not exceed 2500 IU.
引用
- Wu J, Huang J, Ma Y, et al. Higher exogenous gonadotrophin doses increase the risk of small for gestational age singletons after fresh embryo transfers. Reprod Biomed Online. 2021. PMID: 35123879. doi:10.1016/j.rbmo.2021.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。